Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort (2022)
- Authors:
- USP affiliated authors: SQUIRE, JEREMY ANDREW - FMRP ; DUTRA, WILLIAM LAUTERT - FMRP ; SILVA, FRANCISCO CESAR DE SOUSA E - FMRP
- Unidade: FMRP
- DOI: 10.1158/1538-7445.AM2022-6099
- Subjects: EXPRESSÃO GÊNICA; NEOPLASIAS; PRÓSTATA
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2022
- Source:
- Título: Cancer Research
- ISSN: 1538-7445
- Volume/Número/Paginação/Ano: v. 82, n. 12, suppl., res. 6099, 2022
- Conference titles: AACR Annual Meeting
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LAUTERT-DUTRA, William et al. Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2022-6099. Acesso em: 01 jan. 2026. , 2022 -
APA
Lautert-Dutra, W., Melo, C. M., Chaves, L. P., Caliari, A. L., Silva, F. C. de S. e, & Squire, J. A. (2022). Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2022-6099 -
NLM
Lautert-Dutra W, Melo CM, Chaves LP, Caliari AL, Silva FC de S e, Squire JA. Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort [Internet]. Cancer Research. 2022 ; 82( 12):[citado 2026 jan. 01 ] Available from: https://doi.org/10.1158/1538-7445.AM2022-6099 -
Vancouver
Lautert-Dutra W, Melo CM, Chaves LP, Caliari AL, Silva FC de S e, Squire JA. Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort [Internet]. Cancer Research. 2022 ; 82( 12):[citado 2026 jan. 01 ] Available from: https://doi.org/10.1158/1538-7445.AM2022-6099 - Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer
- Interactions between PTEN, TP53, RB1 and TMPRSS2-ERG genes in prostate cancer progression
- Impact of CDK12 loss on immune response in TCGA prostate tumors
- Trannscriptomics and immune response in human cancer
- TCGA analysis identifies distinct genomic features of oncogenic progression and outcome associated with hemizygous PTEN loss tumors
- Impact of CDK12 mutation on immune response in prostate cancer
- Frequência de TP53 na modulação do microambiente tumoral e progressão do câncer da próstata
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
Informações sobre o DOI: 10.1158/1538-7445.AM2022-6099 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003164539.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
